Efficient Induction of Pptide - Specific Cytotoxic T Lymphocytes by LPS - Activated Spleen Cells

スポンサーリンク

概要

• 論文の詳細を見る
• Center for Academic Pub. Japanの論文
• 2000-02-20

著者

• SUGIYAMA Haruo

  Departments of Clinical Laboratory Science

• OKA Yoshihiro

  Department of Molecular Medicine, Osaka University Graduate School of Medicine

• Saito H

  Department Of Hematology Meitetsu Hospital

• Hiraoka Sakamaki

  Department Of Hematology Tokyo Metropolitan Komagome Hospital

• Saito H

  Nagoya Central Hospital

• TAMAMURA Hirokazu

  Graduate School of Pharmaceutical Sciences, Kyoto University

• Oji Yusuke

  Department Of Functional Diagnostic Science Osaka University Graduate School Of Medicine

• Sugiyama H

  Department Of Functional Diagnostic Science Osaka University Graduate School Of Medicine

• Sugiyama Haruo

  Department Of Clinical Laboratory Science Osaka University Medical School

• YAMAGISHI Hideo

  Department of Biophysics, Graduate School of Science, Kyoto University

• Yamagishi Hideo

  Department Of Biophysics Faculty Of Science Kyoto University

• Yamagishi Hideo

  Department Of Biophysics Kyoto Univesity

• Tamamura Hirokazu

  Graduate School Of Pharmaceutical Sciences Kyoto University

• Tamamura Hirokazu

  Graduate School Of Pharmacological Sciences Kyoto University

• UDAKA Keiko

  Department of Immunology, Kochi Medical School

• INABA Kayo

  Department of Animal Development and Physiology, Graduate School of Biostudies, Kyoto University

• Inaba K

  Laboratory Of Immunobiology Department Of Animal Development And Physiology Division Of Systemic Lif

• Udaka Keiko

  Department Of Immunology Kochi Medical School

• Oka Yoshihiro

  Department Of Respiratory Medicine Allergy Rheumatic Diseases Osaka University Graduate School Of Me

• KAKUGAWA Kiyokazu

  Department of Biophysics, Kyoto Univesity

• NAKASHIMA Kosuke

  Department of Zoology, Kyoto Univesity

• Kakugawa Kiyokazu

  Department Of Biophysics Kyoto Univesity

• Nakashima K

  Department Of Zoology Kyoto Univesity

• Oka Yoshihiro

  Department of Electronic Chemistry, Tokyo Institute of Technology at Nagatsuta

関連論文

• A SIMPLE AND SELECTIVE HPLC METHOD FOR THE SIMULTANEOUS DETERMINATION OF PARAQUAT AND DIQUAT IN HUMAN URINE
• Allogeneic stem cell transplantation versus chemotherapy as post-remission therapy for intermediate or poor risk adult acute myeloid leukemia : results of the JALSG AML97 study
• Phase II study of tacrolimus and methotrexate for prophylaxis of acute graft-versus-host disease after HLA-A, B, and DRB1 genotypically mismatched unrelated bone marrow transplantation among Japanese patients
• Activated protein C resistance in the Japanese population due to homozygosity for the factor V R2 haplotype
• Outcome of allogeneic bone marrow transplantation from unrelated donors for adult Philadelphia chromosome-negative acute lymphocytic leukemia in first complete-remission
• Molecular monitoring of BAALC expression in patients with CD34-positive acute leukemia
• Successful treatment of relapsed T-cell non-Hodgkin's lymphoma with allogeneic peripheral blood stem cell transplantation with double conditioning
• Successful treatment of relapsed T-cell non-Hodgkin's lymphoma with allogeneic peripheral blood stem cell transplantation with double conditioning
• Monitoring Minimal Residual Disease in Leukemia Using Real-time Quantitative Polymerase Chain Reaction for Wilms Tumor Gene (WT1)
• Expression of the Wilms' Tumor Gene WT1 in Solid Tumors and Its Involvement in Tumor Cell Growth
• Expression of the Wilms' Tumor Gene WT1 in Solid Tumors and Its Involvement in Tumor Cell Growth
• Long-term efficacy of imatinib in a practical setting is correlated with imatinib trough concentration that is influenced by body size : a report by the Nagasaki CML Study Group
• Peripheral blood stem cell versus bone marrow transplantation from HLA-identical sibling donors in patients with leukemia : a propensity score-based comparison from the Japan Society for Hematopoietic Stem Cell Transplantation registry
• Chronic Graft-versus-Host Disease following Varicella-Zoster Virus Infection in Allogeneic Stem Cell Transplant Recipients
• Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
• Identification of amino acid residues responsible for von Willebrand factor binding to sulfatide by charged-to-alanine-scanning mutagenesis
• Hematopoietic stem cell transplantation for acute promyelocytic leukemia in second or third complete remission : a retrospective analysis in the Nagoya Blood and Marrow Transplantation Group
• Diagnosis of acute myeloid leukemia according to the WHO classification in the Japan Adult Leukemia Study Group AML-97 protocol
• Recurrent Mutations of Factor XI Gene in Japanese
• Structural Organization and Promoter Activity of the Human Ryudocan Gene
• Imatinib Provides Durable Molecular and Cytogenetic Responses in a Practical Setting for Both Newly Diagnosed and Previously Treated Chronic Myelogenous Leukemia : A Study in Nagasaki Prefecture, Japan
• Recurrent Intramural Hematoma of the Small Intestine in a Severe Hemophilia A Patient with a High Titer of Factor VIII Inhibitor : A Case Report and Review of the Literature
• High Titer of ADAMTS13 Inhibitor Associated with Thrombotic Microangiopathy of the Gut and Skeletal Muscle after Allogeneic Hematopoietic Stem Cell Transplantation
• Synthesis of a CC Chemokine, vMIP-II, Encoded by Kaposi's Sarcoma-Associated Herpesvirus and Its Biological Activity
• Unmanipulated Reduced-Intensity Stem Cell Transplantation from a Haploidentical Donor Mismatched at 3 HLA Antigens to a Patient with Leukemic Transformation of Myelodysplastic Syndrome : Successful Second Transplantation after Graft Rejection
• Clinical Trial to Investigate the Pharmacokinetics, Pharmacodynamics, Safety, and Efficacy of Recombinant Factor VIIa in Japanese Patients With Hemophilia With Inhibitors
• The Chemokine Receptor CXCR4 as a Therapeutic Target for Several Diseases Including AIDS, Cancer and Rheumatoid Arthritis
• New Leads of Low Molecular Weight CXCR4 Antagonists Based on Enhancement of the T140-based Pharmacophores
• A New Strategy for Molecular-size Reduction of Bioactive Peptide, Using Two Orthogonal Libraries of Cyclic peptides
• Sensitive immunohistochemical detection of WT1 protein in tumors with anti-WT1 antibody against WT1 235 peptide
• High frequencies of less differentiated and more proliferative WT1-specific CD8^+ T Cells in bone marrow in tumor-bearing patients : An important role of bone marrow as a secondary lymphoid organ
• Safety and efficacy of rasburicase (SR29142) in a Japanese phase II study
• Biased usage of BV gene families of T-cell receptors of WT1 (Wilms' tumor gene)-specific CD8^+ T cells in patients with myeloid malignancies
• Use of foscarnet for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation from a related donor
• Human Herpesvirus 6 Meningoencephalitis in Allogeneic Hematopoietic Stem Cell Transplant Recipients
• Overexpression of the Wilms' tumor gene WT1 in pancreatic ductal adenocarcinoma
• Individual Dose Adjustment of Oral Busulfan Using a Test Dose in Hematopoietic Stem Cell Transplantation
• Molecular Cloning, Genomic Organization, Promoter Activity, and Tissue-Specific Expression of the Mouse Ryudocan Gene^1
• Analysis for heterozygosity of protein S mRNA: application to genetic screening and family studies in hereditary protein S deficiency
• Interferon-α treatment of acute lymphoblastic leukemia relapse after unrelated bone marrow transplantation
• Granulocyte colony-stimulating factor-combined marrow-ablative chemotherapy and autologous blood cell transplantation for the treatment of patients with acute myelogenous leukemia in first remission
• Long-term Follow-up of 14 Patients with Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia following Autologous Bone Marrow Transplantation in First Complete Remission
• A new marrow T cell depletion method using anti-CD6 monoclonal antibody-conjugated magnetic beads and its clinical application for prevention of acute graft-vs.-host disease in allogeneic bone marrow transplantation: results of a phase I-II trial
• Safe switching from dasatinib to nilotinib after a 1-month off-drug period for persistent pleural effusion in patients with chronic myelogenous leukemia in chronic phase
• Successful treatment of refractory advanced nasal NK/T cell lymphoma with unrelated cord blood stem cell transplantation incorporating focal irradiation
• Second unrelated cord blood transplantation using a reduced-intensity conditioning regimen combined with gemtuzumab ozogamicin in patients with relapsed acute myelogenous leukemia
• Impact of Cytogenetics on Outcome of Stem Cell Transplantation for Acute Myeloid Leukemia in First Remission : A Large-Scale Retrospective Analysis of Data from the Japan Society for Hematopoietic Cell Transplantation
• Quality of Life in Adult Patients After Stem Cell Transplantation
• Superior Efficacy of MMCP Regimen Compared with VMCP and MMPP Regimens in the Treatment of Multiple Myeloma
• Posttreatment Nadir M-Protein Level Is a Stronger Discriminator of Survival Following Plateau Attainment Than Is Percent Reduction in M-Protein in Patients With IgG Myeloma
• Rituximab for the treatment of corticosteroid-refractory chronic graft-versus-host disease
• Molecular remission achieved by interferon therapy in a patient with cytogenetically relapsed chronic myelogenous leukemia after syngeneic bone marrow transplantation
• Clinical features of dasatinib-induced large granular lymphocytosis and pleural effusion
• Successful treatment using tacrolimus ointment for cutaneous graft-versus-host disease
• Low-Dose Cyclosporin A with Short-Term Methotrexate for Graft-versus-Host Disease Prophylaxis in Allogeneic Bone Marrow Transplantation from Human Leukocyte Antigen-Identical Siblings : A Prospective Phase II Study in Japanese Patients
• Twenty Years' Experience in Allogeneic Hematopoietic Stem Cell Transplantation for Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia in the Nagoya Blood and Marrow Transplantation Group
• Classic Polyarteritis Nodosa Presenting Rare Clinical Manifestations in a Patient with Hemophilia A
• Identification of the regulatory elements of the human von Willebrand factor for binding to platelet GPIb. Importance of structural integrity of the regions flanked by the CYS1272-CYS1458 disulfide bond
• Identification of six novel MYH9 mutations and genotype-phenotype relationships in autosomal dominant macrothrombocytopenia with leukocyte inclusions
• Identification of plasma antibody epitopes and gene abnormalities in Japanese hemophilia a patients with factor VIII inhibitor
• Immune response of post-transplant peripheral lymphocytes against the patient pre-B cell line, NAGL-1
• Effect of Depolymerized Holothurian Glycosaminoglycan (DHG) on the Activation of Factor VIII and Factor V by Thrombin
• Recovery of Normal Hematopoiesis after Severe Bone Marrow Aplasia Induced by Interferon-α in a Patient with Chronic Myelogenous Leukemia
• Durable Remission by Sobuzoxane in an HIV-Seronegative Patient with Human Herpesvirus 8-Negative Primary Effusion Lymphoma
• Overexpression of the Wilms' tumor gene WT1 in primary astrocytic tumors
• Overexpression of the Wilms' tumor gene WT1 in primary thyroid cancer
• Overexpression of the Wilms' tumor gene WT1 in human bone and soft-tissue sarcomas
• Wilms Tumor Gene WT1 Peptide-Based Immunotherapy Induced a Minimal Response in a Patient with Advanced Therapy-Resistant Multiple Myeloma
• WT1_, a Ninemer Peptide Derived from Wilms' Tumor Gene Product, Is a Candidate Peptide for the Vaccination of HLA-A^*0201-Positive Patients with Hematopoietic Malignancies
• Successful Treatment of Tacrolimus (FK506)-Related Leukoencephalopathy with Cerebral Hemorrhage in a Patient Who Underwent Nonmyeloablative Stem Cell Transplantation
• WT1 Peptide-Based Immunotherapy for Patients with Lung Cancer : Report of Two Cases
• Wilms Tumor Gene Peptide-Based Immunotherapy for Patients with Overt Leulemia from Myelodysplastic Syndrome (MDS) or MDS with Myelofibrosis
• The lck Promoter-Driven Expression of the Wilms Tumor Gene WT1 Blocks Intrathymic Differentiation of T-Lineage Cells
• Wilms' tumor gene WT1 17AA(-)/KTS(-) isoform induces morphological changes and promotes cell migration and invasion in vitro
• Overexpression of the Wilms' tumor gene WT1 in colorectal adenocarcinoma
• Novel Synthesized Trimannose Conjugate Induces Endocytosis and Expression of Immunostimulatory Molecules in Monocytic Leukemia Cells
• Genetic Abnormalities of Bernard-Soulier Syndrome
• Retrospective study of inhibitor formation in Japanese hemophiliacs
• WT1 (Wilms' Tumor 1) Peptide Immunotherapy for Renal Cell Carcinoma
• Wegener's granulomatosis detected initially by integrated 18F-fluorodeoxyglucose positron emission tomography/computed tomography
• Overexpression of the Wilms′tumor gene WT1 in head and neck squamous cell carcinoma
• Early treatment of CMV antigenemia with ganciclovir for prevention of fatal CMV disease in patients receiving marrow from HLA-matched unrelated donors
• Efficient Induction of Pptide - Specific Cytotoxic T Lymphocytes by LPS - Activated Spleen Cells
• Interferon-α and zidovudine for relapsed/refractory adult T cell leukemia/lymphoma : case reports of Japanese patients
• Identification of a WT1 protein-derived peptide, WT1_, : as a HLA-A^*0206-restricted, WT1-specific CTL epitope
• A WT1 protein-derived, naturally processed 16-mer peptide, WT1_, is a promiscuous helper peptide for induction of WT1-specific Th1-type CD4^+ T cells
• Unrelated Bone Marrow Transplantation Induced Long-Term Remission in a Patient with Life-Threatening Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis
• 原発性胆汁性肝硬変に全身性エリテマトーデスを合併した2例
• 多発性筋炎を合併した自己免疫性肝炎の1例
• 肝機能異常を伴った多発性骨髄腫の1例
• Analysis of bacteremia/fungemia and pneumonia accompanying acute myelogenous leukemia from 1987 to 2001 in the Japan Adult Leukemia Study Group
• Incidence, risk factors and outcomes of bronchiolitis obliterans after allogeneic stem cell transplantation
• Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia : a retrospective safety analysis
• Successful treatment of acquired hemophilia A, complicated by chronic GVHD, with tocilizumab
• Osteonecrosis of the humeral head
• Clinical Features and Outcomes of 35 Disseminated Intravascular Coagulation Cases Treated with Recombinant Human Soluble Thrombomodulin at a Single Institution
• Advances in therapies for acute promyelocytic leukemia
• Copy-number variations on the X chromosome in Japanese patients with mental retardation detected by array-based comparative genomic hybridization analysis
• Successful treatment by donor lymphocyte infusion of adult T-cell leukemia/lymphoma relapse following allogeneic hematopoietic stem cell transplantation
• Initial low-dose valganciclovir as a preemptive therapy is effective for cytomegalovirus infection in allogeneic hematopoietic stem cell transplant recipients

もっと見る 閉じる

スポンサーリンク